Deutsche Bank Initiates Coverage On Gilead Sciences with Hold Rating, Announces Price Target of $75
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst James Shin has initiated coverage on Gilead Sciences with a Hold rating and a price target of $75.
November 09, 2023 | 10:17 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Deutsche Bank has initiated coverage on Gilead Sciences with a Hold rating and a price target of $75.
The Hold rating from Deutsche Bank suggests that the bank sees Gilead Sciences' stock as fairly valued at current levels. The price target of $75 indicates where the bank believes the stock will trade in the near future. This news is highly relevant to Gilead Sciences and could influence investor sentiment, but it's not necessarily a strong buy or sell signal, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100